Clinical Trial

AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease

Study acronym: AI-ACLD
Completed
View on ClinicalTrials.gov →
Summary
The research project studies the possibility of using an artificial intelligence-based system in patients with advanced chronic liver disease (liver cirrhosis) to record variations in a patient's health status, with the aim of early identification of clinical improvement or deterioration. The system is based on the collection and processing of various clinical parameters through an Apple Watch. The study aims to evaluate whether the data generated by this system correlate with patients' clinical evolution and whether its use may ultimately contribute to improved care management and quality of life.
Trial Details
NCT Number NCT07721454
Lead Sponsor Antonio Galante
Conditions Advance Chronic Liver Disease (ACLD)
Enrollment 8 participants
Start Date 2022-12-29
Primary Completion 2024-01-17 (estimated)
Study Completion 2024-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-23